1. Home
  2. CMCT vs PHIO Comparison

CMCT vs PHIO Comparison

Compare CMCT & PHIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Creative Media & Community Trust Corporation

CMCT

Creative Media & Community Trust Corporation

HOLD

Current Price

$2.81

Market Cap

12.8M

Sector

Real Estate

ML Signal

HOLD

Logo Phio Pharmaceuticals Corp.

PHIO

Phio Pharmaceuticals Corp.

HOLD

Current Price

$1.05

Market Cap

11.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CMCT
PHIO
Founded
1993
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.8M
11.2M
IPO Year
1996
2011

Fundamental Metrics

Financial Performance
Metric
CMCT
PHIO
Price
$2.81
$1.05
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$14.00
AVG Volume (30 Days)
18.9K
410.8K
Earning Date
05-08-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$116,669,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.06
$0.81
52 Week High
$14.41
$4.19

Technical Indicators

Market Signals
Indicator
CMCT
PHIO
Relative Strength Index (RSI) 42.72 50.70
Support Level $2.78 $1.00
Resistance Level $3.71 $1.14
Average True Range (ATR) 0.30 0.08
MACD 0.01 0.01
Stochastic Oscillator 45.75 70.00

Price Performance

Historical Comparison
CMCT
PHIO

About CMCT Creative Media & Community Trust Corporation

Creative Media & Community Trust Corp is a Maryland corporation and REIT. It mainly acquires, develops, owns, and operates both multifamily properties situated in vibrant communities throughout the United States and Class A and creative office real assets in markets with similar business and employment characteristics to multifamily investments. All of its communities are located in areas that include traditional downtowns and suburban main streets, which have high barriers to entry, high population density, positive population trends, and a propensity for growth. Currently, the company consists of three types of commercial real estate properties, namely office, hotel, and multifamily.

About PHIO Phio Pharmaceuticals Corp.

Phio Pharmaceuticals Corp is a clinical-stage biopharmaceutical company whose proprietary INTASYL small-interfering RNA gene silencing technology is designed to make immune cells more effective in killing tumor cells. Its pipeline programs are PH-762 and PH-894. The group is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems. It is committed to discovering and developing cancer treatments for patients by creating new pathways toward a cancer-free future. The Company operates with a single operating segment, the Clinical segment, and all assets are located in the United States.

Share on Social Networks: